Fundraising FoxJupiter Neurosciences, Inc.
NASDAQ: JUNS1 known investors
Find your way into Jupiter Neurosciences, Inc.
Sign up to find every way you can get introduced to Jupiter Neurosciences, Inc.
- Your email: who you already know at Jupiter Neurosciences, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Jupiter Neurosciences, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Jupiter Neurosciences is a biopharmaceutical company developing JOTROL, a patented micellar oral formulation of resveratrol designed to cross the blood-brain barrier for central nervous system treatment. Its focus is developing therapies for Alzheimer's disease and rare "orphan" diseases.
Founders & leadership
CR
MH
Marshall HaywardChief Scientific Officer and Director
AD
Alison D. SilvaPresident and Chief Operating Officer, and Director
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountRegistered Direct OfferingAug 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Valuation · disclosed
Disclosed events$131.5Mvaluation at IPODec 2024 · $4.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
In the news
Frequently asked questions
- What does Jupiter Neurosciences, Inc. do?
- Jupiter Neurosciences is a biopharmaceutical company developing JOTROL, a patented micellar oral formulation of resveratrol designed to cross the blood-brain barrier for central nervous system treatment. Its focus is developing therapies for Alzheimer's disease and rare "orphan" diseases.
- Who founded Jupiter Neurosciences, Inc.?
- Jupiter Neurosciences, Inc. was founded by Christer Rosén, Marshall Hayward.
- Who are Jupiter Neurosciences, Inc.'s investors?
- Jupiter Neurosciences, Inc.'s investors include Tarnagulla Ventures.